Hypoalbuminemia clinical trials

The registry lists 41 studies for Hypoalbuminemia across more than 10 countries. 9 are recruiting or about to start. 16 of them are mainly about Hypoalbuminemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-13.

Get an email when these change. Save the Hypoalbuminemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 22
Not yet recruiting: 7
Status unknown: 4
Terminated: 4
Recruiting: 2
Active, not recruiting: 1

Phase

Phase 4: 8
Phase 3: 6
Phase 1: 2
Phase 2: 1

Where

United States: 8
China: 5
France: 3
Turkey: 3
Italy: 1
Egypt: 1

Who runs them

Assiut University (3) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2) · Healthgen Biotechnology Corp. (2) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2) · University of Texas Southwestern Medical Center (1) · The Second Affiliated Hospital of Hainan Medical University (1) · University Hospital, Strasbourg, France (1) · Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital (1)

What is being tested here

Drugs under test in Hypoalbuminemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Edoxaban	1	0	1
Albumins human	0	1	5
Drugs, Investigational	0	0	1
Dalteparin	0	0	1
Apixaban	0	0	1
Human serum albumin, recombinant rice-derived	0	1	1
Coenzyme Q10	0	1	1
Thalidomide	0	1	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Jul 2027Rice-derived Recombinant Human Serum Albumin for the Treatment of Hypoalbuminemia After Hepatectomy: A Prospective, Single-Arm, Exploratory Clinical Trial · Cheng Qi
Oct 2027Effect of Albumin Therapy in Mechanically Ventilated Patients With Sepsis-Associated ARDS · The Second Affiliated Hospital of Hainan Medical University

Who these studies take

Of the 2 Hypoalbuminemia studies recruiting now, 1 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	1 (50%)	1 (50%)

Across all 41 studies, recruiting or not: 22% stop at 75 or younger and 15% at 65; 12% take children; 0% are for women only and 2% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 41 of 41. search them.